Log In
Print
BCIQ
Print
Print this Print this
 

Piromelatine (Neu-P11)

  Manage Alerts
Collapse Summary General Information
Company Neurim Pharmaceuticals Ltd.
DescriptionMelatonin MT1 and MT2 receptor agonist and serotonin (5-HT1A) and 5-HT1D receptor agonist
Molecular Target Melatonin MT1 receptor ; Serotonin (5-HT1A) receptor
Mechanism of ActionMelatonin MT1 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInsomnia
Indication DetailsTreat primary insomnia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today